参考文献/References:
[1] Gibson CMSchomig A. Coronary and myocardial angiography:angiographic assessment of both epicardial and myocardial perfusion[J]. Circulation,2004,109(25):3096-3105.
[2] Gibson CM,Cannon CP,Daley WL,et al. TIMI frame count:a quantitative method of assessing coronary artery flow[J]. Circulation,1996,93(5):879-888.
[3] Lopez-Hidalgo M,Eblen-Zajjur A. Coronary blood flow measurement in conventional coronary angiograms by a new method based on contrast density detection. a physiological insight[J]. Arq Bras Cardiol,2020,115(3):503-512.
[4] 何东方刘梅颜张丽军等. 冠状动脉中度狭窄伴胸痛患者的冠状动脉微循环阻力状况及其相关因素分析[J]. 中华内科杂志2018,57(4):270-274.
[5] Enge I,Nitter-Hauge S. Left coronary artery contrast transit time[J]. Br J Radiol,1975,48(566):108-112.
[6] Haridasan V,Nandan D,Raju D,et al. Coronary sinus filling time:a novel method to assess microcirculatory function in patients with angina and normal coronaries[J]. Indian Heart J,2013,65(2):142-146.
[7] Hagemann CA,Hoffmann S,Hagemann RA,et al. Usefulness of layer-specific strain in diagnosis of coronary artery disease in patients with stable angina pectoris[J]. Int J Cardiovasc Imaging,2019,35(11):1989-1999.
[8] Skaarup KG,Iversen A,Jorgensen PG,et al. Association between layer-specific global longitudinal strain and adverse outcomes following acute coronary syndrome[J]. Eur Heart J Cardiovasc Imaging,2018,19(12):1334-1342.
[9] Zhang L,Wu WC,Ma H,et al. Usefulness of layer-specific strain for identifying complex CAD and predicting the severity of coronary lesions in patients with non-ST-segment elevation acute coronary syndrome:compared with Syntax score[J]. Int J Cardiol,2016,223:1045-1052.
[10] Wang Y,Ma C,Zhang Y,et al. Assessment of left and right ventricular diastolic and systolic functions using two-dimensional speckle-tracking echocardiography in patients with coronary slow-flow phenomenon[J]. PLoS One,2015,10(2):e117979.
[11] Haridasan V,Nandan D,Raju D,et al. Coronary sinus filling time:a novel method to assess microcirculatory function in patients with angina and normal coronaries[J]. Indian Heart J,2013,65(2):142-146.
[12] Rampidis GP,Benetos G,Benz DC,et al. A guide for Gensini Score calculation[J]. Atherosclerosis,2019,287:181-183.
[13] Leclercq F. Anatomy and physiology of the heart and coronary arteries[J]. Soins,2015,(793):28-31.
[14] Gibson CM,Cannon CP,Daley WL,et al. TIMI frame count:a quantitative method of assessing coronary artery flow[J]. Circulation,1996,93(5):879-888.
[15] Pride YB,Mohanavelu S,Zorkun C,et al. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention:an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy[J]. JACC Cardiovasc Interv,2012,5(9):927-935.
[16] Diez-Delhoyo F,Gutierrez-Ibanes E,Fernandez-Aviles F. Functional disorders in non-culprit coronary arteries and their implications in patients with acute myocardial infarction[J]. Trends Cardiovasc Med,2020,30(6):346-352.
[17] Onishi T,Saha SK,Delgado-Montero A,et al. Global longitudinal strain and global circumferential strain by speckle-tracking echocardiography and feature-tracking cardiac magnetic resonance imaging:comparison with left ventricular ejection fraction[J]. J Am Soc Echocardiogr,2015,28(5):587-596.
[18] Luis SA,Chan J,Pellikka PA. Echocardiographic assessment of left ventricular systolic function:an overview of contemporary techniques,including speckle-tracking echocardiography[J]. Mayo Clin Proc,2019,94(1):125-138.
[19] Buckberg GD,Clemente C,Cox JL,et al. The structure and function of the helical heart and its buttress wrapping. Ⅳ. The normal macroscopic structure of the heart[J]. Semin Thorac Cardiovasc Surg,2001,13(4):301-319.
[20] Chen W,Zhu W,Wang Y. Evaluation of myocardial perfusion and systolic function in patients with different degree of coronary artery stenosis by MCE and 2D-STI[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2020,45(1):35-39.
[21] 张洁樊继绪任斐等. 经胸超声心动图评估冠脉循环时间的可行性分析[J]. 南京医科大学学报(自然科学版)2016,36(2):228-230.
[22] Eriksseen J,Enge I. Left coronary artery transit time in latent coronary heart disease[J]. Acta Radiol Diagn (Stockh),1977,18(4):385-391.
[23] Enge I,Nitter-Hauge S. Left coronary artery contrast transit time[J]. Br J Radiol,1975,48(566):108-112.
[24] Padro T,Manfrini O,Bugiardini R,et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ’coronary microvascular dysfunction in cardiovascular disease’[J]. Cardiovasc Res,2020,116(4):741-755.
[25] Gibson CM,Kirtane AJ,Murphy SA,et al. Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic,electrocardiographic,and clinical outcomes following thrombolytic administration in acute myocardial infarction[J]. Catheter Cardiovasc Interv,2001,53(1):6-11.
[26] Ding S,Shi Y,Sun X,et al. Contrast agent dose and slow/no-reflow in percutaneous coronary interventions:a case-control study of patients with non-ST-segment elevation acute coronary syndromes[J]. Herz,2019,44(1):69-75.
[27] Ul AR,Ahmedani M,Karim M,et al. Correlation between gensini score and duration of diabetes in patients undergoing coronary angiography[J]. Cureus,2019,11(2):e4010.
[28] Leung M,Leung DY. Coronary microvascular function in patients with type 2 diabetes mellitus[J]. EuroIntervention,2016,11(10):1111-1117.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(10):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(10):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(10):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(10):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(10):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(10):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(10):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(10):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(10):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(10):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]